BMF seems to occur because of a progressive decline of CD34+ cells in the BM compartment, probably starting in the uterus; however, FA-deficient mice can develop various grades of BMF after treatment with cross-linking agents without showing the complete FA phenotype [125]. This evidence concerns the gene CD34 and Friedreich ataxia.